Effect of Angiotensin II Type 2 Receptor-Interacting Protein on Adipose Tissue Function via Modulation of Macrophage Polarization

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Jing, Fei ^a   Mogi, Masaki ^a   Min, Li Juan ^a   Ohshima, Kousei ^a   Nakaoka, Hirotomo ^a   Tsukuda, Kana ^a   Wang, Xiaoli ^a   Iwanami, Jun ^a   Horiuchi, Masatsugu ^a  

^a EHIME UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANGIOTENSIN II TYPE 2 RECEPTOR INTERACTING PROTEIN 1; CARRIER PROTEIN; INTERLEUKIN 10; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADIPOSE TISSUE MACROPHAGE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW TRANSPLANTATION; CELL SIZE; CHOLESTEROL DIET; CONTROLLED STUDY; GENE EXPRESSION; HEMATOPOIETIC CELL; INNATE IMMUNITY; INSULIN RESISTANCE; MACROPHAGE; MACROPHAGE FUNCTION; MACROPHAGE MIGRATION; MACROPHAGE POLARIZATION; MALE; MOLECULAR PATHOLOGY; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEIN FUNCTION; WHITE ADIPOSE TISSUE;

ADIPOKINES; ADIPOSE TISSUE; ADIPOSE TISSUE, WHITE; ANIMALS; BONE MARROW CELLS; CARRIER PROTEINS; CYTOKINES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIET; GLUCOSE; HYPERTROPHY; INFLAMMATION; INFLAMMATION MEDIATORS; MACROPHAGES; MALE; MICE; MICE, TRANSGENIC; TUMOR SUPPRESSOR PROTEINS;

MUS; MUS MUSCULUS;

EID: 84875683178     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060067     Document Type: Article

References (60)

1. Nouet S, Amzallag N, Li JM, Louis S, Seitz I, et al. (2004) Trans-inactivation of receptor tyrosine kinases by novel angiotensin II AT2 receptor-interacting protein, ATIP. J Biol Chem 279: 28989-28997.
2. Wruck CJ, Funke-Kaiser H, Pufe T, Kusserow H, Menk M, et al. (2005) Regulation of transport of the angiotensin AT2 receptor by a novel membrane-associated Golgi protein. Arterioscler Thromb Vasc Biol 25: 57-64.
3. Seibold S, Rudroff C, Weber M, Galle J, Wanner C, et al. (2003) Identification of a new tumor suppressor gene located at chromosome 8p21.3-22. FASEB J 17: 1180-1182.
4. Di Benedetto M, Pineau P, Nouet S, Berhouet S, Seitz I, et al. (2006) Mutation analysis of the 8p22 candidate tumor suppressor gene ATIP/MTUS1 in hepatocellular carcinoma. Mol Cell Endocrinol 252: 207-215.
5. Frank B, Bermejo JL, Hemminki K, Sutter C, Wappenschmidt B, et al. (2007) Copy number variant in the candidate tumor suppressor gene MTUS1 and familial breast cancer risk. Carcinogenesis 28: 1442-1445.
6. Fujita T, Mogi M, Min LJ, Iwanami J, Tsukuda K, et al. (2009) Attenuation of cuff-induced neointimal formation by overexpression of angiotensin II type 2 receptor-interacting protein 1. Hypertension 53: 688-693.
7. Ouchi N, Parker JL, Lugus JJ, Walsh K, (2011) Adipokines in inflammation and metabolic disease. Nat Rev Immunol 11: 85-97.
8. Romeo GR, Lee J, Shoelson SE, (2012) Metabolic syndrome, insulin resistance, and roles of inflammation-mechanisms and therapeutic targets. Arterioscler Thromb Vasc Biol 32: 1771-1776.
9. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808.
10. Qatanani M, Lazar MA, (2007) Mechanisms of obesity-associated insulin resistance: many choices on the menu. Genes Dev 21: 1443-1455.
11. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830.
12. Hotamisligil GS, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
13. Lumeng CN, Bodzin JL, Saltiel AR, (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117: 175-184.
14. Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, et al. (2009) Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 58: 2574-2582.
15. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL, (1993) In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci U S A 90: 12040-12044.
16. Subramanian S, Han CY, Chiba T, McMillen TS, Wang SA, et al. (2008) Dietary cholesterol worsens adipose tissue macrophage accumulation and atherosclerosis in obese LDL receptor-deficient mice. Arterioscler Thromb Vasc Biol 28: 685-691.
17. Bie J, Zhao B, Song J, Ghosh S, (2010) Improved insulin sensitivity in high fat- and high cholesterol-fed Ldlr-/- mice with macrophage-specific transgenic expression of cholesteryl ester hydrolase: role of macrophage inflammation and infiltration into adipose tissue. J Biol Chem 285: 13630-13637.
18. Shiuchi T, Nakagami H, Iwai M, Takeda Y, Cui T, et al. (2001) Involvement of bradykinin and nitric oxide in leptin-mediated glucose uptake in skeletal muscle. Endocrinology 142: 608-612.
19. Sudo M, Minokoshi Y, Shimazu T, (1991) Ventromedial hypothalamic stimulation enhances peripheral glucose uptake in anesthetized rats. Am J Physiol 261: E298-303.
20. Iwanami J, Mogi M, Tsukuda K, Min LJ, Sakata A, et al. (2011) Effect of angiotensin II type 2 receptor deletion in hematopoietic cells on brain ischemia-reperfusion injury. Hypertension 58: 404-409.
21. Greenberg AS, Obin MS, (2006) Obesity and the role of adipose tissue in inflammation and metabolism. Am J Clin Nutr 83: 461S-465S.
22. Ohashi K, Kihara S, Ouchi N, Kumada M, Fujita K, et al. (2006) Adiponectin replenishment ameliorates obesity-related hypertension. Hypertension 47: 1108-1116.
23. Hotamisligil GS, Shargill NS, Spiegelman BM, (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
24. Alberti KG, Zimmet P, Shaw J, (2005) The metabolic syndrome-a new worldwide definition. Lancet 366: 1059-1062.
25. Shoelson SE, Lee J, Goldfine AB, (2006) Inflammation and insulin resistance. J Clin Invest 116: 1793-1801.
26. de Luca C, Olefsky JM, (2008) Inflammation and insulin resistance. FEBS Lett 582: 97-105.
27. Neels JG, Olefsky JM, (2006) Inflamed fat: what starts the fire? J Clin Invest 116: 33-35.
28. Kanda H, Tateya S, Tamori Y, Kotani K, Hiasa K, et al. (2006) MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 116: 1494-1505.
29. Gordon S, (2003) Alternative activation of macrophages. Nat Rev Immunol 3: 23-35.
30. Raes G, Brys L, Dahal BK, Brandt J, Grooten J, et al. (2005) Macrophage galactose-type C-type lectins as novel markers for alternatively activated macrophages elicited by parasitic infections and allergic airway inflammation. J Leukoc Biol 77: 321-327.
31. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A, (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23: 549-555.
32. Wellen KE, Hotamisligil GS, (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112: 1785-1788.
33. Kullo IJ, Hensrud DD, Allison TG, (2002) Comparison of numbers of circulating blood monocytes in men grouped by body mass index (<25, 25 to <30,>or = 30). Am J Cardiol 89: 1441-1443.
34. Soukas A, Cohen P, Socci ND, Friedman JM, (2000) Leptin-specific patterns of gene expression in white adipose tissue. Genes Dev 14: 963-980.
35. Aparicio-Vergara M, Shiri-Sverdlov R, de Haan G, Hofker MH, (2010) Bone marrow transplantation in mice as a tool for studying the role of hematopoietic cells in metabolic and cardiovascular diseases. Atherosclerosis 213: 335-344.
36. Saberi M, Woods NB, de Luca C, Schenk S, Lu JC, et al. (2009) Hematopoietic cell-specific deletion of toll-like receptor 4 ameliorates hepatic and adipose tissue insulin resistance in high-fat-fed mice. Cell Metab 10: 419-429.
37. Cudejko C, Wouters K, Fuentes L, Hannou SA, Paquet C, et al. (2011) p16INK4a deficiency promotes IL-4-induced polarization and inhibits proinflammatory signaling in macrophages. Blood 118: 2556-2566.
38. Dawson J, Miltz W, Mir AK, Wiessner C, (2003) Targeting monocyte chemoattractant protein-1 signalling in disease. Expert Opin Ther Targets 7: 35-48.
39. Deshmane SL, Kremlev S, Amini S, Sawaya BE, (2009) Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res 29: 313-326.
40. Geissmann F, Jung S, Littman DR, (2003) Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19: 71-82.
41. Nahrendorf M, Pittet MJ, Swirski FK, (2010) Monocytes: protagonists of infarct inflammation and repair after myocardial infarction. Circulation 121: 2437-2445.
42. Gordon S, Taylor PR, (2005) Monocyte and macrophage heterogeneity. Nat Rev Immunol 5: 953-964.
43. Sunderkotter C, Nikolic T, Dillon MJ, Van Rooijen N, Stehling M, et al. (2004) Subpopulations of mouse blood monocytes differ in maturation stage and inflammatory response. J Immunol 172: 4410-4417.
44. Takeuchi O, Akira S, (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820.
45. Medzhitov R, Horng T, (2009) Transcriptional control of the inflammatory response. Nat Rev Immunol 9: 692-703.
46. Charo IF, (2007) Macrophage polarization and insulin resistance: PPARgamma in control. Cell Metab 6: 96-98.
47. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, et al. (2010) The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol 11: 936-944.
48. Ohshima K, Mogi M, Jing F, Iwanami J, Tsukuda K, et al. (2012) Direct angiotensin II type 2 receptor stimulation ameliorates insulin resistance in type 2 diabetes mice with PPARgamma activation. PLoS One 7: e48387.
49. Horiuchi M, Yamada T, Hayashida W, Dzau VJ, (1997) Interferon regulatory factor-1 up-regulates angiotensin II type 2 receptor and induces apoptosis. J Biol Chem 272: 11952-11958.
50. Horiuchi M, Koike G, Yamada T, Mukoyama M, Nakajima M, et al. (1995) The growth-dependent expression of angiotensin II type 2 receptor is regulated by transcription factors interferon regulatory factor-1 and-2. J Biol Chem 270: 20225-20230.
51. Rodrigues-Ferreira S, Nahmias C, (2010) An ATIPical family of angiotensin II AT2 receptor-interacting proteins. Trends Endocrinol Metab 21: 684-690.
52. Schaefer KL, (2008) PPARgamma inhibitors as novel tubulin-targeting agents. PPAR Res 2008: 785405.
53. Schaefer KL, Takahashi H, Morales VM, Harris G, Barton S, et al. (2007) PPARgamma inhibitors reduce tubulin protein levels by a PPARgamma, PPARdelta and proteasome-independent mechanism, resulting in cell cycle arrest, apoptosis and reduced metastasis of colorectal carcinoma cells. Int J Cancer 120: 702-713.
54. Sica A, Mantovani A, (2012) Macrophage plasticity and polarization: in vivo veritas. J Clin Invest 122: 787-795.
55. Zaynagetdinov R, Sherrill TP, Polosukhin VV, Han W, Ausborn JA, et al. (2011) A critical role for macrophages in promotion of urethane-induced lung carcinogenesis. J Immunol 187: 5703-5711.
56. Kim HY, DeKruyff RH, Umetsu DT, (2010) The many paths to asthma: phenotype shaped by innate and adaptive immunity. Nat Immunol 11: 577-584.
57. Di Benedetto M, Bieche I, Deshayes F, Vacher S, Nouet S, et al. (2006) Structural organization and expression of human MTUS1, a candidate 8p22 tumor suppressor gene encoding a family of angiotensin II AT2 receptor-interacting proteins, ATIP. Gene 380: 127-136.
58. Li JM, Mogi M, Tsukuda K, Tomochika H, Iwanami J, et al. (2007) Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Mol Endocrinol 21: 499-511.
59. Nahmod KA, Vermeulen ME, Raiden S, Salamone G, Gamberale R, et al. (2003) Control of dendritic cell differentiation by angiotensin II. FASEB J 17: 491-493.
60. Yamada H, Akishita M, Ito M, Tamura K, Daviet L, et al. (1999) AT2 receptor and vascular smooth muscle cell differentiation in vascular development. Hypertension 33: 1414-1419.